| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/09/1998 | WO1998014220A2 TECHNETIUM-99m LABELED CHELATOR INCORPORATED CYCLIC PEPTIDES |
| 04/09/1998 | WO1998014208A1 Reactive ligands and covalent ligand-protein complexes |
| 04/09/1998 | CA2645721A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2267664A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2267467A1 Technetium-99m labeled chelator incorporated cyclic peptides that bind to the gpiib/iiia receptor as imaging agents |
| 04/09/1998 | CA2266752A1 Telomerase reverse transcriptase |
| 04/08/1998 | EP0834572A2 Alpha, gamma-diaminobutyric acid (DAB) containing oligopeptide derivatives |
| 04/08/1998 | EP0833930A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 04/08/1998 | EP0833845A1 Compounds with growth hormone releasing properties |
| 04/08/1998 | EP0833843A2 Depigmenting activity of agouti signal protein and peptides thereof |
| 04/08/1998 | EP0833842A1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 04/08/1998 | EP0833840A1 Hypoxia inducible factor-1 and method of use |
| 04/08/1998 | EP0833836A1 Conformationally-restricted combinatorial library composition and method |
| 04/08/1998 | EP0833835A1 Obesity protein intermediates and their preparation and use |
| 04/08/1998 | EP0833653A1 Serum immunoregulatory polypeptides and uses therefor |
| 04/08/1998 | EP0833652A1 Novel kappa receptor selective opioid peptides |
| 04/08/1998 | EP0833648A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES |
| 04/08/1998 | EP0833646A1 Multi-tyrosinated somatostatin analogs |
| 04/08/1998 | EP0512042B1 Glp-1 analogs useful for diabetes treatment |
| 04/08/1998 | CN1178535A Therapeutic compound-fatty acid conjugates |
| 04/08/1998 | CN1178106A Cyclosphorin-containing soft capsule preparation |
| 04/07/1998 | US5736521 Administering amino acid compound |
| 04/07/1998 | US5736507 Peptide of human cartilage glycoprotein 39, which stimulates autoreactive t-cells found in blood of rheumatoid arthritis patients |
| 04/07/1998 | US5736339 Method utilizing purified GP IIb-IIIa to detect the presence of platelet aggregation inhibitors |
| 04/07/1998 | US5736337 Inhibiting protein interactions |
| 04/07/1998 | US5736336 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 04/07/1998 | US5736315 Methods and compositions for detecting anti-hepatitis E virus activity |
| 04/07/1998 | US5736143 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/07/1998 | US5736142 Alteration of immune response using pan DR-binding peptides |
| 04/07/1998 | US5736122 A specific binding peptide having amino acid sequence of 4 to 100 amino acids and technitium-99m binding moiety covalently linked to specific binding peptide, where in peptide binds to a component of a thrombus |
| 04/07/1998 | CA1339808C Glycopeptide antibiotics |
| 04/02/1998 | WO1998013377A1 Cytotoxic peptides |
| 04/02/1998 | WO1998013376A1 Inhibitors of pla¿2? |
| 04/02/1998 | WO1998013374A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 04/02/1998 | WO1998013063A1 Cyclic peptide antitumor agent from an ascidian |
| 04/02/1998 | WO1998013007A2 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | WO1998002454A3 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 04/02/1998 | CA2267179A1 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | CA2266746A1 Inhibitors of pla2 |
| 04/02/1998 | CA2266329A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 04/02/1998 | CA2263134A1 Cytotoxic peptides |
| 04/02/1998 | CA2213257A1 Oligopeptide derivatives |
| 04/01/1998 | EP0832972A2 Cloning, expression and production of tasty peptides |
| 04/01/1998 | EP0832249A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 04/01/1998 | EP0832223A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION |
| 04/01/1998 | EP0832204A1 Treatment of insulin resistance |
| 04/01/1998 | EP0832129A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders |
| 04/01/1998 | EP0832120A2 Anti-fungal d-amino acid histatin-based peptides |
| 04/01/1998 | EP0832119A2 Anti-fungal and anti-bacterial histatin-based peptides |
| 04/01/1998 | EP0832108A1 Process for recovering water-insoluble compounds from a fermentation broth |
| 04/01/1998 | EP0832107A1 An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine |
| 04/01/1998 | EP0832106A2 Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity |
| 04/01/1998 | EP0832104A1 Novel dolastatin derivatives, their preparation and use |
| 04/01/1998 | EP0832103A1 Cocoa flavour precursor peptides, dna encoding them, processes for producing the peptides, and their use for generating cocoa flavour |
| 04/01/1998 | EP0832068A1 Stable reagents for the preparation of radiopharmaceuticals |
| 04/01/1998 | EP0831939A1 Structurally determined metallo-constructs and applications |
| 04/01/1998 | EP0831895A1 Tumor associated epitopes |
| 04/01/1998 | EP0831880A1 Antibody and antibody fragments for inhibiting the growth of tumors |
| 04/01/1998 | EP0831878A1 Novel peptide inhibitors of calmodulin |
| 04/01/1998 | EP0831872A1 Polypeptide compounds that form beta sheets |
| 03/31/1998 | US5734034 Nucleic acid ligand inhibitors of human neutrophil elastase |
| 03/31/1998 | US5734018 Biosynthesis detection, analyzing method to obtain peptide sequences |
| 03/31/1998 | US5734013 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same |
| 03/31/1998 | US5733879 Peptides and proteins, process for their preparation and their use as cholesterol acceptors |
| 03/31/1998 | US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 03/31/1998 | CA2040441C Fusion proteins |
| 03/31/1998 | CA1339793C Cyclic analogs of atrial natriuretic peptides |
| 03/26/1998 | WO1998012331A1 Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
| 03/26/1998 | WO1998012219A1 Methionine, penicillamine and cysteine-analogue containing peptides having immunomodulating activity |
| 03/26/1998 | WO1998012218A1 Tri- or polysulphide containing peptides having immunomodulating activity |
| 03/26/1998 | WO1998012217A1 Heterodimer peptides with immunomodulatory effect |
| 03/26/1998 | WO1998012216A1 Methionine containing peptides having immunomodulatory effect |
| 03/26/1998 | WO1998012215A1 Penicillamine containing peptides having immunomodulatory effect |
| 03/26/1998 | WO1998012214A1 Cysteine analogue containing peptides having immunomodulatory effect |
| 03/26/1998 | WO1998012213A2 Cysteine containing peptides |
| 03/26/1998 | WO1998011907A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 03/26/1998 | CA2265571A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 03/26/1998 | CA2236165A1 Novel polypeptide from haemophilus paragallinarum and process for preparing the same |
| 03/25/1998 | EP0830372A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability |
| 03/25/1998 | EP0624163B1 Cyclic calcitonin derivatives and method for their production |
| 03/25/1998 | CN1176966A Production process |
| 03/25/1998 | CN1176826A Cyclosporin-containing topical pharmaceutical compostion |
| 03/25/1998 | CN1037857C Method for preparing peptide derivatives by using black chain mould |
| 03/24/1998 | US5731489 Transgenic rats containing at least one human gene which participates in blood pressure control |
| 03/24/1998 | US5731289 Bridged dipeptide compounds which have a stimulating activity on cell division, especially in myelopoietic and bone marrow cells |
| 03/24/1998 | US5731286 Cyclic neurokinin A antagonists |
| 03/24/1998 | US5731285 Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 03/24/1998 | US5731159 Heat stable receptor protein contacted with detectable antibodies |
| 03/19/1998 | WO1998011126A1 Peptide prodrugs containing an alpha-hydroxyacid linker |
| 03/19/1998 | WO1998010792A1 Immune direction therapy |
| 03/19/1998 | WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders |
| 03/19/1998 | WO1998010780A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF |
| 03/19/1998 | WO1998010651A1 Conjugates useful in the treatment of prostate cancer |
| 03/19/1998 | CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders |
| 03/19/1998 | CA2265476A1 Conjugates useful in the treatment of prostate cancer |
| 03/19/1998 | CA2265454A1 Peptide prodrugs containing an alpha-hydroxyacid linker |
| 03/19/1998 | CA2264563A1 Isolated peptides which complex with hla-cw*16 molecules, and uses thereof |
| 03/18/1998 | EP0828521A1 Sequestered imaging agents |
| 03/18/1998 | EP0606481B1 Herbicide containing cyclic hexapeptide as active ingredient |
| 03/18/1998 | EP0563329B1 Angiogenic peptides |